Co-founded in 2016 by an oncologist and a computer scientist, Owkin designs machine learning technologies to accelerate drug discovery and to develop personalized medicine. Based in New York and in Paris, Owkin works in collaboration with pharmaceutical companies, hospitals and academic labs to build the tools to advance the future of medicine, from target discovery to drug development and precision medicine, leveraging big data and machine learning algorithms.

Visit website

Buttontwitter

As Featured In

Original
Original
Original
Original
Original
Original

Partners & Attendees

Intel.001
Nvidia.001
Graphcoreai.001
Ibm watson health 3.001
Facebook.001
Acc1.001
Rbc research.001
Twentybn.001
Forbes.001
Maluuba 2017.001
Mit tech review.001
Kd nuggets.001